Focus Partners Advisor Solutions
GOSS icon

Focus Partners Advisor Solutions’s Gossamer Bio GOSS Stock Holding History

Focus Partners Advisor Solutions’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49K Buy
341
+13
+4% +$290 ﹤0.01% 1243
2026
Q1 		$8.63K Buy
+328
New +$41.2K ﹤0.01% 1249

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Focus Partners Advisor Solutions's GOSS Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Gossamer Bio (GOSS) stake by 4% in Q2 2026, buying an estimated $290 and bringing the position to 341 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Focus Partners Advisor Solutions first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.63K in Q1 2026. 167 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Focus Partners Advisor Solutions held 341 shares of Gossamer Bio worth $4.49K as of Q2 2026.
  • Focus Partners Advisor Solutions bought 13 Gossamer Bio shares in Q2 2026, an estimated $290.
  • Gossamer Bio made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1243 holding.
  • Focus Partners Advisor Solutions first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Focus Partners Advisor Solutions's Gossamer Bio position peaked at $8.63K in Q1 2026.
  • 167 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.